International Cannabis Weekly: 57
Highlights
Business & Investment
- MedMen announces listing on the Frankfurt Stock Exchange.
- GW Pharma’s Epidiolex will cost patients €28,000 per year on average in the US.
- European company recognised as the ‘Bloomberg of cannabis’.
- EU Cannabis Corp has applied for a Greek medical cannabis licence.
- German-based Clearstream Banking will continue to support cannabis companies.
- Harvey Nichols expands the distribution of MGC Derma products in the UK.
- Canadian producer Kaneh Bosm set to acquire Slovenian medical cannabis firm.
Highlights
Regulation & Politics
- Welsh police chief signals support for Spanish-style cannabis collectives.
- Politicians call for medical cannabis legislation in Northern Ireland.
- Malta rejects calls for recreational use as medical cannabis enters pharmacies.
- Belgian shops are selling CBD products despite unclear legal guidelines.
Highlights
Health & Science
- The British Paediatric Neurology Association guidelines prevent THC treatment.
- Canopy announces clinical trial approval for the use of cannabis to treat anxiety.
- The first cannabis roadside testing device is about to be approved in Canada.
Highlights
International
- Cannabis companies raised a total of €6.9 billion in 2018.
- ABcann announces global rebrand to VIVO Cannabis.
- Lebanese farmers hope legal cannabis will restore the declining agricultural industry.
- Scythian-owned Colcanna receives licence to import and cultivate THC in Colombia.
- Canopy completes the full acquisition of Spectrum Cannabis Chile.
- MYM and Dutch Passion sign agreement to distribute cannabis seeds in Colombia.
- House of Representatives in the Northern Mariana Islands approves cannabis bill.
- A large majority of Australians support medical cannabis.
- Heineken has released their first non-alcoholic cannabis beer.
Highlights
Sponsorship Opportunities
Prohibition Partners is currently seeking sponsorship partners to support our thought-leading industry reports. This is a unique opportunity to be part of the latest research and insights into the European cannabis market and put your brand in front of the industries decision makers. For more information, please contact info@prohibitionpartners.com.
Highlights
The European Cannabis Report
Prohibition Partners are pleased to announce the release of the 3rd Edition of The European Cannabis Report™. The report explores the medical, recreational, and industrial cannabis industries across 28 key European states. Identifying the commercial, legal, and social trends affecting the European market, the report provides a detailed analysis into what will become the world’s largest cannabis market.
Highlights
European Country Panel
Prohibition Partners is delighted to announce the launch of The European Country Panel, an online community of thought leaders in the European cannabis industry. This panel brings together selected members of the industry, representing over 28 countries, to share information, discuss ideas and develop new opportunities. If you are interested in joining the European Country Panel, please contact our Community Manager, Olivia Rutter, at olivia@prohibitionpartners.com.
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.